Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?

Journal of Dermatological Science

Volumn 81, Issue 1, 2016, Pages 3-9

  Xie, Heng ^a   Zhou, Fubo ^a   Liu, Ling ^a   Zhu, Guannan ^a   Li, Qiang ^a   Li, Chunying ^a   Gao, Tianwen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cellular immunity; Cytotoxic T lymphocyte; Reactive oxygen species; Vitiligo

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA INTERMEDIN; ANTIOXIDANT; AUTOANTIGEN; CALRETICULIN; CYTOKINE; DNA; HEAT SHOCK PROTEIN 70; MELANIN; PIMECROLIMUS; QUERCETIN; REACTIVE OXYGEN METABOLITE; TACROLIMUS;

ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; AUTOPHAGY; CELL DAMAGE; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; EPIDERMIS; EXOSOME; GENETIC POLYMORPHISM; HUMAN; MELANOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ULTRAVIOLET RADIATION; UNFOLDED PROTEIN RESPONSE; VITILIGO; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; DNA DAMAGE; IMMUNOLOGY; MELANOSOME; METABOLISM;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; DNA DAMAGE; HUMANS; MELANOCYTES; MELANOSOMES; MODELS, IMMUNOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VITILIGO;

EID: 84955377516     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.09.003     Document Type: Review

References (50)

1. Ezzedine K., Eleftheriadou V., Whitton M., van Geel N. Vitiligo. Lancet. 2015, 386(9988):74-84.
2. Glassman S.J. Vitiligo, reactive oxygen species and T-cells. Clin. Sci. 2011, 120:99-120.
3. Laddha N.C., Dwivedi M., Mansuri M.S., Gani A.R., Ansarullah M., Ramachandran A.V., et al. Vitiligo: interplay between oxidative stress and immune system. Exp. Dermatol. 2013, 22:245-250.
4. Sandoval-Cruz M., García-Carrasco M., Sánchez-Porras R., Mendoza-Pinto C., Jiménez-Hernández M., Munguía-Realpozo P., et al. Immunopathogenesis of vitiligo. Autoimmun. Rev. 2011, 10:762-765.
5. Spritz R.A. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J. Invest. Dermatol. 2011, 132:268-273.
6. Denat L., Kadekaro A.L., Marrot L., Leachman S.A., Abdel-Malek Z.A. Melanocytes as instigators and victims of oxidative stress. J. Invest. Dermatol. 2014, 134:1512-1518.
7. Rama R., ao G., Rao A., Moorthy B., Rao T., Sravani P.V., Babu N., et al. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J. Dermatol. Venereol. Leprol. 2009, 75:268.
8. Jain A., Mal J., Mehndiratta V., Chander R., Patra S.K. Study of oxidative stress in vitiligo. Indian J. Clin. Biochem. 2011, 26:78-81.
9. Dell'Anna M.L., Ottaviani M., Bellei B., Albanesi V., Cossarizza A., Rossi L., et al. Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. J. Cell Physiol. 2010, 223(1):187-193.
10. Trouba K.J., Hamadeh H.K., Amin R.P., Germolec D.R. Oxidative stress and its role in skin disease. Antioxid. Redox Signal. 2002, 4:665-673.
11. Al-Shobaili H.A., Rasheed Z. Oxidized tyrosinase: a possible antigenic stimulus for non-segmental vitiligo autoantibodies. J. Dermatol. Sci. 2015, 10.1016/j.jdermsci.2015.06.009.
12. He J., Li X., Li Y., Ren B., Sun J., Zhang W., et al. Lack of association between the 389C > T polymorphism (rs769217) in the catalase (CAT) gene and the risk of vitiligo: An update by meta-analysis. Australas J. Dermatol. 2015, 56(3):180-185.
13. Goth L., Nagy T. Inherited catalase deficiency: is it benign or a factor in various age related disorders. Mutat. Res. 2013, 753:147-154.
14. 2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J. Invest. Dermatol. 2014, 134:2221-2230.
15. Bickers D.R., Athar M. Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 2006, 126:2565-2575.
16. Bellei B., Pitisci A., Ottaviani M., Ludovici M., Cota C., Luzi F., et al. Vitiligo: a possible model of degenerative diseases. PLoS One 2013, 8:e59782.
17. Prignano F., Pescitelli L., Becatti M., Di G., ennaro P., Fiorillo C., Taddei N., et al. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J. Dermatol. Sci. 2009, 54:157-167.
18. Boissy R.E., Liu Y.Y., Medrano E.E., Nordlund J.J. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J. Invest. Dermatol. 1991, 97:395-404.
19. Becatti M., Fiorillo C., Barygina V., Cecchi C., Lotti T., Prignano F., et al. SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival. J. Cell. Mol. Med. 2014, 18:514-529.
20. Choi H., Shin J., Lee H., Kim J., Huh C., Youn S., et al. Potential redox-sensitive Akt activation by dopamine activates bad and promotes cell death in melanocytes. Oxid. Med. Cell. Longev. 2010, 3:219-224.
21. Wang Q., Jiang M., Wu J., Ma Y., Li T., Chen Q., et al. Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro. Cell Death Dis. 2014, 5:e1022.
22. 2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J. 2009, 23:3790-3807.
23. Wei C., Jian Z., Wang L., Qiang H., Shi Q., Guo S., et al. Genetic variants of the APE1 gene and the risk of vitiligo in a Chinese population: a genotype-phenotype correlation study. Free Radic. Biol. Med. 2013, 58:64-72.
24. Palermo B., Campanelli R., Garbelli S., Mantovani S., Lantelme E., Brazzelli V., et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J. Invest. Dermatol. 2001, 117:326-332.
25. Huang C.L., Nordlund J.J., Boissy R. Vitiligo a manifestation of apoptosis?. Am. J. Clin. Dermatol. 2002, 3:301-308.
26. Wang X., Erf G.F. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo. J. Autoimmun. 2004, 22:21-30.
27. Farrukh M.R., Nissar U.A., Afnan Q., Rafiq R.A., Sharma L., Amin S., et al. Oxidative stress mediated Ca(2+) release manifests endoplasmic reticulum stress leading to unfolded protein response in UV-B irradiated human skin cells. J. Dermatol. Sci. 2014, 75:24-35.
28. Toosi S., Orlow S.J., Manga P. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J. Invest. Dermatol. 2012, 132:2601-2609.
29. van den Boorn J.G., Melief C.J., Luiten R.M. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. Pigm. Cell Melanoma Res. 2011, 24:673-679.
30. van den Boorn J.G., Picavet D.I., van Swieten P.F., van Veen H.A., Konijnenberg D., van Veelen P.A., et al. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J. Invest. Dermatol. 2011, 131:1240-1251.
31. Becker J.C., Schrama D. Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?. J. Invest. Dermatol. 2011, 131:1185-1187.
32. Mosenson J.A., Zloza A., Klarquist J., Barfuss A.J., Guevara-Patino J.A., Le Poole I.C. HSP70i is a critical component of the immune response leading to vitiligo. Pigm. Cell Melanoma Res. 2012, 25:88-98.
33. Mosenson J.A., Eby J.M., Hernandez C., Le Poole I.C. A central role for inducible heat-shock protein 70 in autoimmune vitiligo. Exp. Dermatol. 2013, 22:566-569.
34. Zhang Y., Liu L., Jin L., Yi X., Dang E., Yang Y., et al. Oxidative stress-induced Calreticulin expression and translocation: new insights into the destruction of melanocytes. J. Invest. Dermatol. 2013, 134:183-191.
35. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123:321-334.
36. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B., Marysael T., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 2012, 31:1062-1079.
37. Schmid D., Pypaert M., Münz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
38. Mosenson J.A., Flood K., Klarquist J., Eby J.M., Koshoffer A., Boissy R.E., et al. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigm. Cell Melanoma Res. 2014, 27:209-220.
39. Millar D.G., Garza K.M., Odermatt B., Elford A.R., Ono N., Li Z., et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 2003, 9:1469-1476.
40. Mosenson J.A., Zloza A., Nieland J.D., Garrett-Mayer E., Eby J.M., Huelsmann E.J., et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci. Transl. Med. 2013, 5:128r-174r.
41. Sanchez-Sosa S., Aguirre-Lombardo M., Jimenez-Brito G., Ruiz-Argüelles A. Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo. Clin. Exp. Immunol. 2013, 173:179-183.
42. Abdallah M., Lotfi R., Othman W., Galal R. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo. Int. J. Dermatol. 2014, 53:940-946.
43. Itoi S., Tanemura A., Kotobuki Y., Wataya-Kaneda M., Tsuruta D., Ishii M., et al. Coexistence of Langerhans cells activation and immune cells infiltration in progressive nonsegmental vitiligo. J. Dermatol. Sci. 2014, 73:83-85.
44. van den Boorn J.G., Konijnenberg D., Dellemijn T.A.M., van der Veen J.P.W., Bos J.D., Melief C.J.M., et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J. Invest. Dermatol. 2009, 129:2220-2232.
45. Le Gal F., Avril M., Bosq J., Lefebvre P., Deschemin J., Andrieu M., et al. Direct Evidence to support the role of antigen-specific CD8+ T cells in melanoma-associated vitiligo. J. Invest. Dermatol. 2001, 117:1464-1470.
46. 2 with topical NB-UVB-activated pseudocatalase PC-KUS. FASEB J. 2013, 27:3113-3122.
47. Speeckaert R., Speeckaert M.M., van Geel N. Why treatments do(n't) work in vitiligo: an autoinflammatory perspective. Autoimmun. Rev. 2015, 14:332-340.
48. 2 on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes. Mol. Med. Rep. 2015, 11:4285-4290.
49. Ito T., Kimura S., Seto K., Warabi E., Kawachi Y., Shoda J., et al. Peroxiredoxin I plays a protective role against UVA irradiation through reduction of oxidative stress. J. Dermatol. Sci. 2014, 74:9-17.
50. Barygina V., Becatti M., Lotti T., Moretti S., Taddei N., Fiorillo C. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J. Dermatol. Sci. 2015.